All News

It's been a busy week for the Contemporary OB/GYN® team. Here's a look at what you missed.

Women with severe menopausal symptoms are likely to experience significantly greater cognitive decline than their counterparts with mild menopausal symptoms, according to a cross-sectional study in the journal Menopause.

Payments are meant to assist providers who have been impacted by the COVID-19 pandemic.

Difficulties accessing virtual care and support remain a barrier to the best care for patients facing complex conditions.

For preeclampsia, multifetal gestation was the most common high-risk factor among pregnant patients who gave birth in the United States in 2019.

Americans want the technology available, but most prefer in-person visits.

These results suggest that maternal diet during pregnancy can significantly affect obesity risk in children.

The COVID-19 global pandemic has broad implications for obstetrical care and perinatal outcomes. As we approach the 2-year mark into an unprecedented international pandemic, this review presents the progress and opportunities for research related to COVID-19 and pregnancy.

First-time visits up sharply, study finds.

Women with non-albicans Candida (NAC) vulvovaginal candidiasis (VVC) were nearly twice as likely to have multiple physician visits for recurring infections compared to women who had C. albicans (CA) VVC, according to a retrospective chart review in the Journal of Women’s Health.

An oral probiotic formula for the secondary prevention of vulvovaginal infections in pregnant women neither colonized in the vagina nor reduced the rate of repeated vulvovaginal infection, according to a study in the American Journal of Gynecology & Obstetrics.

A look at what's coming to Contemporary OB/GYN® this week.

Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla) transdermal system.

New trial results showed statistically significant improvements in overall survival and progression-free survival.

Here's what you missed this week from Contemporary OB/GYN®.

Study results show that fetal cognitive development in the assessed areas was age-appropriate and there was no indication of infection.

COVID-19 updates and news to know as of January 17, 2022.

Scientific advances have led to more extremely preterm infants surviving delivery. What are the outcomes for these infants?

SMFM supports the new NIH COVID-19 Treatment guidelines.

New study results suggest that severe depression and sexual dysfunction, in particular, can affect a woman's attention, language, orientation, recall, registration, and visuospatial skills.

There are a number of effective treatments, but a recent study sought to investigate how well oral contraceptives in particular could help reduce symptoms—while preserving sexual quality of life—in women with particularly severe forms of endometriosis.

These mothers are approximately 17% less likely to die from cardiovascular disease, 14% less likely to develop coronary heart disease, and 12% less likely to suffer a stroke, the data show.

A phase 2, multicenter study has found relugolix (Myfembree; Myovant Sciences) significantly decreases menstrual blood loss in women with uterine leiomyomas and is mostly well tolerated. Relugolix is a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.

A clinical study has confirmed that the pathophysiology of recurrent vulvovaginal candidiasis (RVVC) relies primarily on Candida albicans (C. albicans)-specific attributes like hyphal morphogenesis, biofilm formation and pathogenesis that differentiate it from other prominent non-albicans C. (NAC) species.

Autophagy is a controlled lysosomal degradation pathway that protects cells and allows to overcome cell death.

The authors noted that both primary options for treatment are currently being debated as to their efficacy and safety.

A case report of infiltrative endometriosis without endometrioma underscores the need to consider endometriosis in the differential for patients with pelvic masses and to recognize possible features that might indicate the diagnosis.